-
-
-
-
-
-
-
Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
-
-
-
-
-
-
-
Ashland (ASH) completes sale of Avoca business to Mane
-
-
-
-
-
-
-
Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions
-
-
-
-
-
-
-
Ashland reports financial results(1) for second quarter of fiscal year 2022 consistent with previous update
-
-
-
-
-
-
-
Ashland reports preliminary financial results1 for third quarter of fiscal year 2021
-
-
-
-
-
-
-
Ashland to acquire personal care business of Schülke & Mayr GmbH, a portfolio company of EQT
-
-
-
-
-
-
-
Ashland mails letter to shareholders highlighting industry analyst and shareholder support
-
1,199,643 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


